Dr. Ann Marie Egloff

Dr. Ann Marie Egloff was born in Owosso, Michigan, in a family where education and community involvement were central values. Her mother, a science teacher, and her father, a school administrator, inspired her to pursue learning and contribute to society. She thrived at Swartz Creek High School, excelling in math and science and earning honors for her academic achievements. In addition to her studies, she was involved in varsity basketball, track and field, diving, student council, theater, and ballet, demonstrating her diverse interests and leadership. Dr. Egloff continued her education at the University of Michigan, earning a Bachelor of Science in Cellular and Molecular Biology. This laid the foundation for her professional career, beginning at Warner-Lambert Parke-Davis. There, she worked on molecular cloning and small-molecule inhibitors to address cancer and metabolic diseases. Her contributions were recognized through employee awards, affirming the value of her work in advancing biomedical research. Her growing interest in disease mechanisms led Dr. Egloff to pursue a PhD in Biochemistry, Cell, and Molecular Biology at Johns Hopkins School of Medicine. Her research focused on immune cell signaling pathways, crucial for understanding how the body responds to various diseases. After earning her PhD, she continued her research at the National Human Genome Research Institute, where she conducted postdoctoral work on cancer-causing gene mutations. Her work in this area earned her recognition for its significant contributions to cancer genetics. Dr. Egloff further expanded her career at the University of Pittsburgh by joining an NIH/NCI-sponsored Cancer Education and Career Development Program. She worked on translating research findings into clinical applications, particularly focused on personalized cancer treatments. As an Assistant Professor at the University of Pittsburgh School of Medicine, she led research on head and neck cancers and helped develop targeted therapies for cancer patients. In 2015, Dr. Egloff transitioned to Boston University, where she continued her research and took on additional roles in mentorship. She currently works at Brigham and Women’s Hospital and Harvard Medical School, where she focuses on tumor immunology and the development of precision cancer treatments. Dr. Ann Marie Egloff’s career is a testament to her commitment to advancing scientific research and improving patient outcomes. Her contributions to cancer research continue to have a profound impact, and she remains dedicated to mentoring future scientists while contributing to her community.